Landscape Capital Management, L.L.C. Alnylam Pharmaceuticals, Inc. Transaction History

Landscape Capital Management, L.L.C.

  • $887 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$138.54 - $232.0 $390,128 - $653,312
2,816 New
2,816 $564,000
Q3 2019

Nov 12, 2019
SELL
$70.9 - $87.82 $1 Million - $1.24 Million
-14,145 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$72.76 - $93.45 $54,133 - $69,526
-744 Reduced 5.0%
14,145 $1.32 Million
Q4 2018

Feb 14, 2019
BUY
$62.67 - $88.33 $933,093 - $1.32 Million
14,889 New
14,889 $1.09 Million

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email